I like this setup in CNAT . Despite the fact CNAT has recently failed a trial, I look at this as an opportunity to run before the next dataset in the 1st half of 2019.
Reasons I believe this is:
Stock has a history of filling all gaps in the chart. Gap at 4.50 currently needs to be filled.
Chart Pattern ( )
Even though it temporarily made historically new lows for the stock, it subsequently rebounded off the long term .
Risks are as follows:
Stock offerings (although they already raised 28.6 million for trials and expenses back in May)
We'll see how it plays out